ArticleThe Journal of biological chemistry2011

Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface.

Alexander Espinosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.